Holen Sie sich die Stockscreener-App
35.57
0.34%
0.12
Handel nachbörslich:
35.57
Schlusskurs vom Vortag:
$35.45
Offen:
$35.49
24-Stunden-Volumen:
398.87K
Relative Volume:
0.72
Marktkapitalisierung:
$1.76B
Einnahmen:
$3.53B
Nettoeinkommen (Verlust:
$30.99M
KGV:
57.99
EPS:
0.6134
Netto-Cashflow:
$154.99M
1W Leistung:
+3.58%
1M Leistung:
-6.66%
6M Leistung:
+45.07%
1J Leistung:
+25.47%
1-Tages-Spanne:
$34.81
$35.97
1-Wochen-Bereich:
$33.54
$36.83
52-Wochen-Spanne:
$18.08
$51.60
Astrana Health Inc Stock (ASTH) Company Profile
Firmenname
Astrana Health Inc
Sektor
Branche
Telefon
(626) 282-0288
Adresse
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH vs HCA, THC, EHC, FMS, DVA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ASTH
Astrana Health Inc
|
35.57 | 1.80B | 3.53B | 30.99M | 154.99M | 0.6134 |
HCA
Hca Healthcare Inc
|
426.74 | 94.31B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
255.56 | 20.91B | 21.46B | 2.65B | 3.35B | 19.23 |
EHC
Encompass Health Corp
|
121.49 | 12.18B | 6.07B | 793.80M | 464.40M | 5.9914 |
FMS
Fresenius Medical Care Ag Adr
|
22.38 | 12.08B | 22.44B | 1.35B | 2.03B | 1.9002 |
DVA
Davita Inc
|
174.92 | 11.39B | 13.84B | 1.10B | 1.49B | 10.42 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-12 | Eingeleitet | Needham | Buy |
| 2025-04-01 | Eingeleitet | Barclays | Equal Weight |
| 2024-10-14 | Eingeleitet | TD Cowen | Buy |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-07-11 | Hochstufung | Truist | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-02-26 | Eingeleitet | Jefferies | Buy |
| 2024-02-22 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-01-24 | Eingeleitet | Stifel | Buy |
| 2023-12-22 | Eingeleitet | Truist | Hold |
| 2023-10-17 | Eingeleitet | BTIG Research | Buy |
| 2023-04-12 | Eingeleitet | BofA Securities | Neutral |
| 2022-12-19 | Eingeleitet | Lake Street | Buy |
| 2022-09-21 | Eingeleitet | William Blair | Outperform |
| 2022-01-11 | Fortgesetzt | Colliers Securities | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Equal Weight |
Alle ansehen
Astrana Health Inc Aktie (ASTH) Neueste Nachrichten
Astrana Health Inc. (ASTH) Stock Forecasts - Yahoo! Finance Canada
Astrana Health Reveals Spoofing Attack Targeting Private Data - Law360
Astrana Health Inc (ASTH) Stock Up 5.6% and Still Undervalued -- GF Score: 88/100 - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Is Investigating Astrana Health, Inc. (ASTH) And Encourages Investors to Connect - accessnewswire.com
Astrana Health faces securities fraud probe aft... - Pluang
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH - PR Newswire
Apollo Medical Holdings Inc (3AM.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bronstein, Gewirtz & Grossman, LLC Is Investigating Astrana Healt - The National Law Review
Astrana buys Prospect's managed care arm for $708M out of bankruptcy - Dealroom
Astrana Health, Inc. (ASTH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Astrana Health, Inc. (ASTH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Why Astrana Health (ASTH) Shares Are Trading Lower Today - Yahoo Finance
Astrana Health Q3 Results: Sales guide $1.000B-$1.030B vs $1.021B est - scanx.trade
Astrana Health Latest Results: Sales guidance affirmed at $3.8B-$4.1B - scanx.trade
Astrana Health FY26 Results: Sales guidance affirmed at $3.800B-$4.100B - scanx.trade
Astrana Health, Inc. - Reuters
Astrana Health Reports Material Cyberattack; Shares Fall Pre-Bell - marketscreener.com
Astrana is latest U.S. healthcare company to face acyberattack - TradingView
Astrana Health (ASTH) Stock May Be Fully Priced As Shares Fell 67% - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Lowey Dannenberg, P.C. is Investigating Astrana Health, - GlobeNewswire
Astrana Health Inc. (ASTH) Stock Analysis: A Promising 54% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Lowey Dannenberg probes Astrana Health after short-seller report - scanx.trade
M&A AwardsDEAL OF THE YEAR$500 MILLION – $1 BILLION HONOREE: Astrana Health acquires Prospect Medical Holdings - Los Angeles Business Journal
Astrana Health: Strong Execution, Still No Re-Rating (NASDAQ:ASTH) - Seeking Alpha
A Look at Astrana Health Inc (ASTH) After 9.0% Decline -- GF Val - GuruFocus
Astrana Health stock tumbles after short report - Investing.com
Astrana Health stock tumbles after short report By Investing.com - Investing.com Canada
Astrana Health Shares Fall After GlassHouse Research Publishes Short-Seller Report - Moomoo
Astrana Health falls amid short call from GlassHouse Research - TradingView
Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know - Yahoo Finance
Form 8K Astrana Health Inc For: 15 September By Investing.com - Investing.com India
Astrana Health updates corporate presentation, reiterates FY2026 guidance and $267.5M adj. EBITDA midpoint - TradingView
Oppenheimer Initiates Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $53 - Moomoo
Oppenheimer Initiates Astrana Health at Outperform With $53 Price Target - marketscreener.com
2 Cash-Producing Stocks with Competitive Advantages and 1 We Turn Down - The Globe and Mail
ETFs Investing in Astrana Health Inc. Stocks - TradingView
Astrana Health CEO Brandon Sim Surrenders Shares to Cover Tax Withholding on RSU Vesting - Kalkine Media
Enterprise value to revenue forward of Astrana Health Inc. – NASDAQ:ASTH - TradingView
Astrana Health (ASTH) exec surrenders shares to cover RSU taxes - Stock Titan
Here’s What Boosted Astrana Health (ASTH) in Q2 - Yahoo Finance
Astrana Health (ASTH) director sells 8,500 shares back to the company at $37.09 - Stock Titan
Astrana (ASTH) Momentum: Posts a 3.15% Loss to $38.11 on the Day; Chart View: Traders Can Monitor the $36.20-$40.02 Range in Latest TradingMomentum Surge Alerts - careplusvn.com
Astrana (ASTH) Range: Moves 1.57% Higher to $39.35 in the Current Update; Boundary Watch - siam.in
Astrana Health (ASTH) Shares Just Moved, So What Is Going On? - Sahm
Astrana Health Director David Schmidt Executes Option Exercise and Sells Shares via Issuer Repurchase - Kalkine Media
Astrana Health (NASDAQ: ASTH) director sells 20K shares back to company - Stock Titan
ASTH | Astrana Health Inc. Common FinancialsRevenue Breakdown - quiverquant.com
Astrana Health (NASDAQ:ASTH) Rating Lowered to Hold at Wall Street Zen - MarketBeat
Astrana Health (ASTH) Surges 7.99% to $40.81 — Key Levels to WatchHigh Beta Stocks - Vinanet
5 Must-Read Analyst Questions From Astrana Health’s Q2 Earnings Call - Yahoo Finance
Finanzdaten der Astrana Health Inc-Aktie (ASTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
Astrana Health Inc-Aktie (ASTH) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Sim Brandon | CEO and President |
Feb 02 '26 |
Option Exercise |
23.24 |
21,334 |
495,802 |
1,045,329 |
| Schmidt David | Director |
Jan 13 '26 |
Option Exercise |
5.79 |
20,000 |
115,800 |
35,763 |
| Lam Thomas S. | Director |
Dec 08 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
459,122 |
| Sim Kenneth T. | Executive Chairman |
Nov 10 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
639,407 |
| Kitayama Mitchell W | Director |
Nov 07 '25 |
Option Exercise |
18.20 |
12,000 |
218,400 |
27,846 |
| Mazdyasni Matthew | Director |
Nov 10 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
34,763 |
| Marsh Linda | Director |
Nov 03 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
103,641 |
1.18%
1.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):